Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note issued to investors on Thursday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

NYSE:AMPE opened at $0.09 on Thursday. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $2.91. The business’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.02. The stock has a market cap of $97,723.50, a price-to-earnings ratio of -0.01 and a beta of 3.67.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.